* Tabula Rasa HealthCare Inc TRHC.OQ TRHC.O is expected
to show a rise in quarterly revenue when it reports results on
February 24.
* The Moorestown New Jersey-based company is expected to
report
a 10.6% increase in revenue to $85.188 million from $77.05
million a year ago, according to the mean estimate from 8
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Tabula Rasa
HealthCare
Inc is for a loss of 8 cents per share. For the same quarter
last year, the company reported a loss of 8 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 6
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Tabula Rasa
HealthCare Inc is $14.3, about 53.6% above its last closing
price of $6.63.
* Previous quarterly performance (using preferred earnings
measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2021 0.02 0.03 -0.04 Missed -218.5
Jun. 30 2021 0.00 0.00 -0.01 Missed -200.3
Mar. 31 2021 -0.09 -0.09 -0.09 Met 2.4
Dec. 31 2020 -0.10 -0.10 -0.08 Beat 17.2
Sep. 0.05 0.04 -0.01 Missed -123.9
30 2020
Jun. 30 2020 0.08 0.06 0.07 Beat 25.4
Mar. 31 2020 -0.03 -0.05 0.01 Beat 120.8
Dec. 31 2019 0.04 0.04 0.13 Beat 251.4
This summary was machine generated February 22 at 21:48 GMT.
All figures in US dollars unless otherwise stated